uranium enrichment

Law firm investigates securities fraud claims against ASP Isotopes, Integer Holdings, Molina Healthcare, and Soleno Therapeutics for alleged misstatements regarding technology, competitive position, medical costs, and drug safety.

Four public companies face securities fraud investigations alleging misrepresentation of core operations, product safety, and regulatory compliance.

Radnostix terminates $12.45M asset sale with American Fuel Resources, retains DUF6 plant assets amid nuclear energy sector revival.

Oklo and Centrus Energy partner on HALEU fuel production. Centrus rated superior due to profitable operations; Oklo years from commercialization despite Meta deal.

Grabar Law Office investigates securities fraud claims against $ASPI, $CWH, $EOSE, and $SLNO for alleged disclosure failures. Long-term shareholders may seek compensation and reforms at no cost.

Palantir and Centrus Energy partner to deploy AI software for uranium enrichment operations, identifying $300 million in potential cost savings.

$UEC reports strong Q2 FY2026 metrics with $101/pound selling prices, sub-$45 costs, and $800M debt-free capital positioning exponential growth.

Oklo and Centrus form nuclear fuel joint venture for HALEU production at Ohio facility, strengthening domestic supply chain for advanced reactors.

Centrus Energy, sole U.S. HALEU producer, poised to benefit from nuclear expansion driven by AI data centers. Stock up 83% with $2.3B order backlog.

AI data center demand and Trump's nuclear expansion policy create supply deficit, boosting uranium suppliers. DOE's $2.7B investment strengthens domestic fuel capacity and market opportunities.